Authorization

DGAP-News: Biotest AG: Biotest reaches revenues of EUR 77.5 million in the first quarter 2019

DGAP-News: Biotest AG / Key word(s): Quarter Results


Biotest AG: Biotest reaches revenues of EUR 77.5 million in the first quarter 2019


07.05.2019 / 10:00



The issuer is solely responsible for the content of this announcement.


PRESS RELEASE

Biotest reaches revenues of EUR 77.5 million in the first quarter 2019

- Guidance confirmed

- Earnings after taxes in the first quarter totalled to EUR -1.2 million


Dreieich, 7 May 2019. In the first quarter of 2019, the Biotest Group reported revenue of EUR 77.5 million. This is a decrease of 11.9 % over the EUR 88.0 million in sales during the same period of the previous year.

EBIT from continuing operations was EUR -9.9 million in the first three months of 2019 (same period of the previous year: EUR -3.0 million). It includes expenses for the Biotest Next Level project of EUR -16.9 million (same period of the previous year: EUR -15.2 million) and income from insurance compensation in the amount of EUR 4 million. The weaker EBIT compared to the previous year is primarily due to lower sales. In addition, a 17.6 % increase in research and development costs had a negative impact on EBIT. The increase is due to the production of clinical material for the development projects IgG Next Generation and Trimodulin.
See also:
Leave a comment
News
  • Latest
  • Read
  • Commented
Calendar Content
«    Сентябрь 2019    »
ПнВтСрЧтПтСбВс
 1
2345678
9101112131415
16171819202122
23242526272829
30